Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,512 articles

Articles by Daniel Marsh

USA Rare Earth Stock Reverses Gains After Serra Verde Deal Dilution
Markets

USA Rare Earth Stock Reverses Gains After Serra Verde Deal Dilution

USA Rare Earth (USAR) shares reversed a 9% gain after closing its Serra Verde deal, issuing 126.85 million shares. The pro forma dilution and production targets weigh on sentiment.

USAR
Sydney Property Market: Indexes Clash on August Price Drop
Markets

Sydney Property Market: Indexes Clash on August Price Drop

Sydney home prices are falling, but two major indexes disagree on the pace: PropTrack says 0.3% monthly drop, while Cotality reports 1.4%.

EWA
BorgWarner Reaffirms AI Power Push: $300M Target, 2 GW Capacity
Analysis

BorgWarner Reaffirms AI Power Push: $300M Target, 2 GW Capacity

BorgWarner reaffirmed its AI data-center power target, expecting $300M in first-year sales and 2 GW capacity by 2027. The stock rose 2.8% on Friday.

BWA
Aehr Test Systems Surges 13% on Heavy Volume, Valuation Still Lofty
Analysis

Aehr Test Systems Surges 13% on Heavy Volume, Valuation Still Lofty

Aehr Test Systems shares surged 13.1% on Friday to $86.26, but the stock remains 40.8% below its August peak. The $2.81 billion valuation is 18.8-21.6 times fiscal 2027 revenue guidance, leaving little room for error.

AEHR
Geely Cuts EX2 Price in Brazil as 35% EV Tariff Nears
Analysis

Geely Cuts EX2 Price in Brazil as 35% EV Tariff Nears

Geely Auto (HKG:0175) launches a Brazilian direct-sales program with a 7% discount on its EX2 EV, as a 35% import tariff raises the stakes for local production. Shares have slipped 9% in a month despite strong export growth.

XTEND Debuts at $6.19, But $75M Earnout Looms Large
Analysis

XTEND Debuts at $6.19, But $75M Earnout Looms Large

XTEND AI Robotics (NYSE:XTND) closed its first trading day at $6.19, but the real challenge lies in its merger agreement: a $64.42 million second-half revenue target to unlock the first earnout.

PDS Biotech Diverts All New Equity Cash to Lender Amid Funding Crunch
Analysis

PDS Biotech Diverts All New Equity Cash to Lender Amid Funding Crunch

PDS Biotech's lender now takes 100% of net cash from new equity deals outside its ATM until a $6M promissory note is repaid, worsening an already tight funding situation.

PDSB
Uber Restructures: 10% Staff Cut, Africa Pullback, London AV Trial
Markets

Uber Restructures: 10% Staff Cut, Africa Pullback, London AV Trial

Uber announces a 10% staff reduction and exits Nigeria and Uganda, while launching a supervised autonomous vehicle trial in London. Shares rose 1.6% on the news.

UBER
Car-Mart Secures Brief Reprieve as Lenders Extend Waiver to Sept. 11
Markets

Car-Mart Secures Brief Reprieve as Lenders Extend Waiver to Sept. 11

America's Car-Mart wins a four-day lender waiver extension, now expiring Sept. 11. The stock remains under pressure as the company seeks a transaction to address its debt.

CRMT
Archer Aviation Warrants Halted as Expiry Nears; ACHR Stock Unaffected
Analysis

Archer Aviation Warrants Halted as Expiry Nears; ACHR Stock Unaffected

NYSE halted trading in Archer Aviation's public warrants ahead of their Sept. 16 expiration. The common stock (ACHR) remains listed and active, with warrants deeply out of the money.

ACHR
SoundHound's LivePerson Deal: Share Dilution vs. Revenue Growth
Markets

SoundHound's LivePerson Deal: Share Dilution vs. Revenue Growth

SoundHound AI closed its LivePerson acquisition, issuing up to 42 million shares. The combined entity posts $114.4M quarterly revenue, but dilution and integration risks loom.

SOUN LPSN
Immuron Stock Soars 62% on U.S. IBS Deal, But Key Details Missing
Markets

Immuron Stock Soars 62% on U.S. IBS Deal, But Key Details Missing

Immuron's stock jumped 62% on a U.S. distribution deal for its IBS product, but with no launch date or revenue details disclosed, the rally may be running on hype.